Sign In
Buy MNLO
$0.555
+0 (+0%)
At Close: Aug 17, 2022
Were Hedge Funds Right About Piling Into Menlo Therapeutics Inc. (MNLO)?
01:03pm, Friday, 07'th Aug 2020
The latest 13F reporting period has come and gone, and Insider Monkey is again at the forefront when it comes to making use of this gold mine of data. We at Insider Monkey have plowed through 821 13F
Menlo Therapeutics Inc. (MNLO) Reports Q2 Loss, Tops Revenue Estimates
03:25pm, Thursday, 06'th Aug 2020
Menlo Therapeutics Inc. (MNLO) delivered earnings and revenue surprises of -476.19% and 472.94%, respectively, for the quarter ended June 2020. Do the numbers hold clues to what lies ahead for the sto
Menlo Reports Second Quarter 2020 Financial Results and Provides Business Update
11:00am, Thursday, 06'th Aug 2020
Conference Call Today at 8:30am Eastern TimeBRIDGEWATER, N.J., Aug. 06, 2020 (GLOBE NEWSWIRE) -- Menlo Therapeutics Inc. (Nasdaq: MNLO) (“Menlo” or the “Company”), a specialty pharmaceutical c
The Daily Biotech Pulse: FDA Nod For GlaxoSmithKline, Bristol-Myers Squibb Earnings, Acutus Medical IPO
12:00am, Thursday, 06'th Aug 2020
Scaling The Peaks
(Biotech Stocks Hitting 52-week Highs Aug. 5)
ABIOMED, Inc. (NASDAQ: ABMD)
Aerpio Pharmaceuticals Inc (NASDAQ: ARPO) (announced a U.S. government grant for a...
Menlo Therapeutics Inc (NASDAQ:MNLO) Given Average Rating of “Buy” by Analysts
06:38am, Tuesday, 04'th Aug 2020
Menlo Therapeutics Inc (NASDAQ:MNLO) has earned an average recommendation of “Buy” from the seven analysts that are currently covering the stock, MarketBeat.com reports. One investment analyst has
The Week Ahead In Biotech: Novavax Coronavirus Vaccine Readout, FDA Decisions And More Earnings
12:00am, Sunday, 02'nd Aug 2020
Biotech stocks came under pressure in the week ended July 31 amid mixed earnings from the sector and some adverse clinical readouts.
COVID-19 news flow continued to pour in,...
Menlo Therapeutics to Report Second Quarter 2020 Financial Results on August 6
12:00pm, Tuesday, 28'th Jul 2020
BRIDGEWATER, N.J., July 28, 2020 (GLOBE NEWSWIRE) -- Menlo Therapeutics Inc. (Nasdaq: MNLO) (“Menlo” or the “Company”), a specialty pharmaceutical company focused on developing and commerciali
Menlo Therapeutics' Enterprise Valuation Equals ~80% Of Estimated Peak Annual Sales Of 2 Recent FDA Approved Products
03:21pm, Wednesday, 22'nd Jul 2020
MNLO's enterprise valuation at $1.70/share is <$200MM (after assuming a $25MM Q22020 cash burn). This is less than 80% of MNLO's estimated peak annual sales of $250MM-$300MM/year.
Two Sigma Advisers LP Reduces Holdings in Menlo Therapeutics Inc (NASDAQ:MNLO)
10:18pm, Wednesday, 15'th Jul 2020
Two Sigma Advisers LP lowered its position in Menlo Therapeutics Inc (NASDAQ:MNLO) by 31.5% during the first quarter, according to its most recent filing with the SEC. The institutional investor owned
Menlo Therapeutics Inc (NASDAQ:MNLO) Shares Acquired by Parametric Portfolio Associates LLC
04:02am, Sunday, 12'th Jul 2020
Parametric Portfolio Associates LLC increased its position in Menlo Therapeutics Inc (NASDAQ:MNLO) by 141.4% in the first quarter, according to the company in its most recent Form 13F filing with the
Insights on the Worldwide Pruritus Industry to 2024 - Track Market Size, Competitor Drug Sales, Market Shares - ResearchAndMarkets.com
12:00am, Wednesday, 01'st Jul 2020
The
Northland Securities Maintains a Buy Rating on Verrica Pharmaceuticals (VRCA) - Markets
11:49am, Tuesday, 30'th Jun 2020
Northland Securities analyst Tim Chiang maintained a Buy rating on Verrica Pharmaceuticals (VRCA – Research Report) today and set a
Investing in Nanotechnology Stocks and Companies
12:04pm, Friday, 26'th Jun 2020
Top Gun was the highest grossing film of the year, “Rock Me Amadeus” by Falco was the #1 single of the year, Cosby Show was the top television show, and the Chicago Bears won the Superbowl. It was
The
Hedge Funds Have Never Been This Bullish On Menlo Therapeutics Inc. (MNLO)
05:21pm, Tuesday, 23'rd Jun 2020
Before we spend countless hours researching a company, we like to analyze what insiders, hedge funds and billionaire investors think of the stock first. This is a necessary first step in our investmen
